| 臺大學術典藏 |
2021-03-05T09:38:15Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; CHUNG-WU LIN; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-23T08:26:37Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu C.; SUNG-HSIN KUO; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2021-02-05T06:29:43Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Hou H.-A.;Huang T.-C.;Lin L.-I.;Liu C.-Y.;Chen C.-Y.;Wen-Chien Chou;Tang J.-L.;Tseng M.-H.;Huang C.-F.;Chiang Y.-C.;Lee F.-Y.;Liu M.-C.;Yao M.;Huang S.-Y.;Ko B.-S.;Hsu S.-C.;Wu S.-J.;Tsay W.;Chen Y.-C.;Tien H.-F.; Hou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; WEN-CHIEN CHOU; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:15Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Ko B.-S.;Wang Y.-F.;Li J.-L.;Li C.-C.;Weng P.-F.;Hsu S.-C.;Hou H.-A.;Huang H.-H.;Yao M.;Lin C.-T.;Liu J.-H.;Tsai C.-H.;Huang T.-C.;Wu S.-J.;Huang S.-Y.;Wen-Chien Chou;Tien H.-F.;Lee C.-C.;Tang J.-L.; Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; WEN-CHIEN CHOU; Tien H.-F.; Lee C.-C.; Tang J.-L. |
| 臺大學術典藏 |
2021-02-05T06:29:11Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.;Lin C.-C.;Lee S.-H.;Tsai C.-H.;Wu S.-J.;Hou H.-A.;Huang T.-C.;Kuo Y.-Y.;Yao M.;Chang K.;Lin C.-W.;Lin Y.-C.;Tien F.-M.;Wen-Chien Chou;Tang J.-L.;Tien H.-F.; Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; WEN-CHIEN CHOU; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-04T02:30:37Z |
Altered balance control in thoracic adolescent idiopathic scoliosis during obstructed gait
|
Wu, K.-W.;Lu, T.-W.;Lee, W.-C.;Ho, Y.-T.;Huang, T.-C.;Wang, J.-H.;Wang, T.-M.Tung-Wu Lu; Wu, K.-W.; Lu, T.-W.; Lee, W.-C.; Ho, Y.-T.; Huang, T.-C.; Wang, J.-H.; Wang, T.-M.; TUNG-WU LU |
| 臺大學術典藏 |
2021-01-28T01:06:49Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Kun-Huei Yeh;Lu Y.S.;Hsu C.H.;Lin J.F.;Chao H.J.;Huang T.C.;Chung C.Y.;Chang C.S.;Yang C.H.;Cheng A.L.; KUN-HUEI YEH; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Huang T.C.; Chung C.Y.; Chang C.S.; Yang C.H.; Cheng A.L. |
| 臺大學術典藏 |
2021-01-28T01:06:44Z |
Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation
|
Huang T.-C.; KUN-HUEI YEH; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:36Z |
Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy
|
Chen W.-W.;Lin C.-C.;Huang T.-C.;Cheng A.-L.;Kun-Huei Yeh;Hsu C.-H.; Chen W.-W.; Lin C.-C.; Huang T.-C.; Cheng A.-L.; KUN-HUEI YEH; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:28Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Huang P.-M.;Lee J.-M.;Hsu F.-M.;Cheng J.C.-H.;Wang H.-P.;Kun-Huei Yeh;Cheng A.-L.;Hsu C.-H.; Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; KUN-HUEI YEH; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:20Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.;Lin C.-C.;Huang T.-C.;Huang P.-M.;Kuo H.-Y.;Chang C.-H.;Wang C.-C.;Cheng J.C.-H.;Kun-Huei Yeh;Hsu C.-H.;Lee J.-M.; Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; KUN-HUEI YEH; Hsu C.-H.; Lee J.-M. |
| 臺大學術典藏 |
2021-01-28T01:06:17Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C.;Lin C.-C.;Wu Y.-C.;Chia-Hsien Cheng J.;Lee J.-M.;Wang H.-P.;Huang P.-M.;Hsu F.-M.;Kun-Huei Yeh;Cheng A.-L.;Tzen K.-Y.;Hsu C.-H.; Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; KUN-HUEI YEH; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-27T07:49:40Z |
New exciplex systems composed of triazatruxene donors and N-heteroarene-cored acceptors
|
Hu, Y.-C.;Lin, Z.-L.;Huang, T.-C.;Lee, J.-W.;Wei, W.-C.;Ko, T.-Y.;Lo, C.-Y.;Chen, D.-G.;Chou, P.-T.;Hung, W.-Y.;Wong, K.-T.; Hu, Y.-C.; Lin, Z.-L.; Huang, T.-C.; Lee, J.-W.; Wei, W.-C.; Ko, T.-Y.; Lo, C.-Y.; Chen, D.-G.; Chou, P.-T.; Hung, W.-Y.; Wong, K.-T.; KEN-TSUNG WONG |
| 臺大學術典藏 |
2021-01-27T06:53:40Z |
Generalized orthonormal moment tensor decomposition and its source-type diagram
|
Huang, T.-C.;Wu, Y.-M.; Huang, T.-C.; Wu, Y.-M.; YIH-MIN WU |
| 臺大學術典藏 |
2021-01-27T03:23:41Z |
Generalized orthonormal moment tensor decomposition and its source-type diagram
|
Huang, T.-C.;Wu, Y.-M.; Huang, T.-C.; Wu, Y.-M.; YIH-MIN WU |
| 臺大學術典藏 |
2021-01-15T03:46:41Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; HSIU-PO WANG; Yeh K.-H.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-15T03:46:26Z |
Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; HSIU-PO WANG; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; Cheng A.-L.; Tzen K.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2021-01-12T12:53:48Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; SHANG-YI HUANG; Chou W.-C.; Tien H.-F.; Lee C.-C.; Tang J.-L. |
| 臺大學術典藏 |
2021-01-12T12:53:47Z |
Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation Registry
|
Huang T.-C.; SHANG-YI HUANG; Yao M.; Lin C.-Y.; Hwang W.-L.; Gau J.-P.; Tan T.-D.; Wang P.-N.; Liu Y.-C.; Lin S.-C.; Kao R.-H.; Pei S.-N.; Yu M.-S.; Lin H.-Y.; Su Y.-C.; Chen C.-C.; Li S.-S.; Wu Y.-Y. |
| 臺大學術典藏 |
2021-01-12T12:49:21Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Huang T.-C.; Ko B.-S.; Tang J.-L.; Hsu C.; Chen C.-Y.; Tsay W.; SHANG-YI HUANG; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:18Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Tsay W.; Hsu S.-C.; Wu S.-J.; Ko B.-S.; SHANG-YI HUANG; Yao M.; Liu M.-C.; Lee F.-Y.; Hou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:47Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Huang T.-C.; Ko B.-S.; JIH-LUH TANG; Hsu C.; Chen C.-Y.; Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:42Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Hou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; JIH-LUH TANG; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:21Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; JIH-LUH TANG |
| 臺大學術典藏 |
2021-01-06T03:58:21Z |
Clonal sequence tracking reveals TET2-mutated extranodal NK/T-cell lymphoma disseminated independent of Epstein Barr virus
|
Yuan C.-T.; Huang T.-C.; Chuang C.-C.; Chuang Y.-K.; Tsai J.-H.; Liau J.-Y.; Lin C.-W.; JIH-LUH TANG |
